Insmed (INSM) Capital Leases (2010 - 2026)
Insmed's Capital Leases came in at $17.62 million for Q3 2026, down 18.4% from $21.6 million a year earlier and down 6.7% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Capital Leases (2010 - 2026) Analysis & Trends
At the end of FY2025, Insmed's Capital Leases was $20.72 million, down 13.9% from FY2024.
- Capital Leases has declined in each of the last three years, though with a five-year compound annual growth rate of 7.1% (FY2020 to FY2025).
- Going back by year, Capital Leases was $24.06 million in FY2024 (-11.0%), $27.03 million in FY2023 (-8.8%), $29.64 million in FY2022 (+110.1%) and $14.1 million in FY2021 (-4.1%).
- The Q3 2026 figure represents the lowest quarterly Capital Leases since Q4 2021.
- Year-over-year, Capital Leases has declined for 12 consecutive quarters, with an average decline of 13.9% over the last eight quarters.
- The fastest year-over-year change in Capital Leases over five years came in Q4 2022 (growth of 110.1%), and the weakest in Q3 2026 (a decline of 18.4%).
- Business Quant data shows INSM's Capital Leases at $18.89 million (Q2 2026), $19.82 million (Q1 2026) and $20.72 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.94 Mn |
| Jun 30, 2026 | 18.89 Mn |
| Mar 31, 2026 | 19.82 Mn |
| Dec 31, 2025 | 20.72 Mn |
| Sep 30, 2025 | 21.60 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Mar 31, 2025 | 23.27 Mn |
| Dec 31, 2024 | 24.06 Mn |
| Sep 30, 2024 | 24.84 Mn |
| Jun 30, 2024 | 25.59 Mn |
| Mar 31, 2024 | 26.32 Mn |
| Dec 31, 2023 | 27.03 Mn |
| Sep 30, 2023 | 27.71 Mn |
| Jun 30, 2023 | 28.37 Mn |
| Mar 31, 2023 | 29.02 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 22.68 Mn |
| Jun 30, 2022 | 23.14 Mn |
| Mar 31, 2022 | 23.51 Mn |
| Dec 31, 2021 | 14.10 Mn |
API Access
Insmed Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();